Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Melanoma Research|September 1, 1992
Fotemustine: an overview of its clinical activity in disseminated malignant melanomaD Khayat, M F Avril, B Gerard, et al.
Bulletin Du Cancer|February 5, 1999
[Irinotecan in combination for colon cancer]M Ducreux, M Gil-Delgado, T André, et al.
Melanoma Research|June 25, 1999
Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?R Mouawad, D Khayat, S Merle, et al.
Therapie|July 8, 1999
[Patient-centered consultation of "good practice guidelines": OncoDoc, a decision support system for the management of breast cancer patients]J Bouaud, B Séroussi, E C Antoine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectivesJ P Spano, R Fagard, J-C Soria, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase I study of Datelliptium chloride, hydrochloride given by 24-h continuous intravenous infusionD Khayat, C Borel, M Azab, et al.
Presse Medicale (Paris, France : 1983)|June 6, 1987
[Human recombinant leukocyte interferon alpha-2-A in 22 cases of metastatic malignant melanoma]J Maral, M Steinberg, M Weil, et al.
Proceedings. AMIA Symposium|February 3, 1999
Hypertextual navigation operationalizing generic clinical practice guidelines for patient-specific therapeutic decisionsJ Bouaud, B Séroussi, E C Antoine, et al.
Anesthesiology|February 1, 1990
Functional and metabolic activity of polymorphonuclear leukocytes from patients with adult respiratory distress syndrome: results of a randomized double-blind placebo-controlled study on the activity of prostaglandin E1M D Rossignon, D Khayat, C Royer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.
Pageof 15